초록 ▼

A method of controlling an injector system for delivering a contrast enhancing fluid to a patient. The method includes the step of determining at least one patient transfer function for the patient based upon data specific to the patient, with the at least one patient transfer function providing a t

A method of controlling an injector system for delivering a contrast enhancing fluid to a patient. The method includes the step of determining at least one patient transfer function for the patient based upon data specific to the patient, with the at least one patient transfer function providing a time enhancement output for a given input. The data specific to the patent may include at least one of an estimate of physiologic parameters of the patient, an estimate of anatomic parameters of the patient and an enhancement caused by an injection of the contrast enhancing fluid into the patient. Other steps involve: determining a desired time enhancement output; using the at least one patient transfer function to determine an injection procedure input; and controlling the injector system at least in part on the basis of the determined injection procedure input.

대표청구항 ▼

1. A method of controlling an injector system for delivering a contrast enhancing fluid to a patient, comprising: (a) determining at least one patient transfer function for the patient based upon data specific to the patient, the at least one patient transfer function providing a time enhancement ou

1. A method of controlling an injector system for delivering a contrast enhancing fluid to a patient, comprising: (a) determining at least one patient transfer function for the patient based upon data specific to the patient, the at least one patient transfer function providing a time enhancement output for a given input, the data specific to the patient including at least one of an estimate of physiological parameters of the patient, an estimate of anatomic parameters of the patient and an enhancement caused by an injection of the contrast enhancing fluid into the patient;(b) determining a desired time enhancement output;(c) using the at least one patient transfer function to determine an injection procedure input; and(d) controlling the injector system at least in part on the basis of the determined injection procedure input. 2. The method of claim 1 wherein the contrast enhancing fluid is a CT contrast enhancing fluid, a MRI contrast enhancing fluid, an ultrasound enhancing imaging fluid or a radioactive contrast enhancing fluid. 3. The method of claim 1 wherein at least two patient transfer functions are determined and the injection procedure input is determined on the basis of one of the patient transfer functions. 4. The method of claim 3 wherein a first patient transfer function is determined using a system identification model comprising parameters related to physiological parameters of the patient and a second patient transfer function is determined using a mathematical model determined by collecting data corresponding to a time enhancement curve resulting from an injection, the mathematical model describing the data. 5. The method of claim 3 wherein a determination is made as to which patient transfer function provides a best correlation between a given input and a resulting output. 6. The method of claim 1 wherein the injection procedure input is determined considering at least one operational limitation or constraint of the injector system. 7. The method of claim 6 wherein the at least one patient transfer function is determined by the steps of: (a) collecting data corresponding to a time response curve resulting from an injection of the fluid; and(b) determining at least one mathematical model describing the data. 8. The method of claim 7 wherein the mathematical model is not determined by a continuous or a discrete-time Fourier transform of the data. 9. The method of claim 7 wherein the model is a parametric model. 10. The method of claim 9 wherein the model is a moving average or an autoregressive moving average. 11. The method of claim 9 wherein the mathematical model assumes linearity and time invariance. 12. The method of claim 7 wherein the model is a non-parametric model determined by a spectral estimation technique. 13. The method of claim 12 wherein the spectral estimation technique is Welch's method, Bartlett's method, a multiple signal classification (MUSIC) method, or a Periodogram method. 14. The method of claim 7 wherein data is collected during at least one test injection prior to an imaging injection. 15. The method of claim 7 wherein the at least one patient transfer function is updated with data collected during an imaging injection. 16. The method of claim 6 wherein the injection procedure input is determined using an analytical solution or using a numerical, constrained optimization technique. 17. The method of claim 16 wherein the numerical, constrained optimization technique is a weighted least-squared numerical optimization. 18. The method of claim 16 wherein the injection procedure input is optimized to minimize a mass of a contrast enhancing agent in the contrast enhancing fluid delivered to the patient. 19. The method of claim 18 wherein the contrast enhancing agent is iodine, xenon or gadolinium. 20. The method of claim 6 wherein the at least one patient transfer function is determined using a system identification model comprising parameters related to the physiological parameters of the patient. 21. The method of claim 20 wherein the system identification model is discretizable. 22. The method of claim 20 further comprising the steps of: (a) developing an initial patient transfer function using estimates of at least one of the physiological parameters of the patient;(b) performing an injection; and(c) revising the patient transfer function based upon at least one time enhancement output of the injection. 23. The method of claim 22 wherein the at least one patient physiological parameter is measured from the at least one time enhancement output. 24. The method of claim 22 wherein the injection is a test injection performed prior to a diagnostic imaging procedure. 25. The method of claim 24 wherein time enhancement outputs resulting from the test injection are measured for at least two different regions of interest. 26. The method of claim 25 wherein a first time enhancement output is measured in an ascending aorta or a descending aorta and a second time enhancement output is measured in a pulmonary artery trunk. 27. The method of claim 25 wherein differences between the time enhancement outputs provide a measure of at least one patient physiological parameter. 28. The method of claim 27 wherein a first time enhancement output is measured in an ascending aorta or a descending aorta and a second time enhancement output is measured in a pulmonary artery trunk. 29. The method of claim 28 wherein the at least one patient physiological parameter is cardiac output, blood volume in a region, a rate transfer term or a transit delay. 30. The method of claim 27 wherein the at least one patient physiological parameter is a parameter of the cardiopulmonary system. 31. The method of claim 30 wherein the at least one patient physiological parameter is cardiac output, blood volume in a region, a rate transfer term or a transit delay. 32. The method of claim 20 wherein the at least one patient transfer function is updated with data collected during an imaging injection. 33. The method of claim 6 wherein the at least one patient transfer function is determined at least in part on the basis of at least one injection. 34. The method of claim 33 wherein the at least one injection is a test injection performed prior to a diagnostic imaging procedure. 35. The method of claim 34 wherein more than one test injection is performed. 36. The method of claim 35 where one test injection comprises injection of a contrast medium only and another test injection comprises injection of a contrast medium followed by injection of a non-contrast fluid. 37. The method of claim 34 wherein the test injection comprises injection of a contrast medium followed by injection of a non-contrast fluid. 38. The method of claim 37 wherein the non-contrast fluid is injected at substantially the same volumetric flow rate as a flow rate of the contrast medium preceding the injection of the non-contrast fluid. 39. The method of claim 38 wherein the non-contrast fluid is saline. 40. An injector system for the delivery of a fluid to a patient comprising: (a) an injector; and(b) a controller in communicative connection with the injector, the controller comprising: (I) at least one patient transfer function determined for the patient based upon data specific to the patient, the at least one patient transfer function providing a time enhancement output for a given input, the data specific to the patient including at least one of an estimate of physiologic parameters of the patient, an estimate of anatomic parameters of the patient and an enhancement caused by an injection of the fluid into the patient; and(II) a processor to determine an injection procedure input for a desired time enhancement output using the at least one patient transfer function. 41. The injector system of claim 40 wherein the injection procedure input is determined considering at least one operational limitation or constraint of the injector. 42. The injector system of claim 40 wherein the injection procedure input is determined using an analytical solution or a numerical, constrained optimization technique. 43. The injector system of claim 42 wherein the numerical, constrained optimization technique is a weighted least-squared numerical optimization. 44. The injector system of claim 42 wherein the injection procedure input is optimized to minimize a mass of a contrast enhancing agent in the fluid delivered to the patient. 45. The injector system of claim 44 wherein the contrast enhancing agent is iodine, xenon or gadolinium. 46. The injector system of claim 40 wherein the fluid is a CT contrast enhancing fluid, a MRI contrast enhancing fluid, an ultrasound enhancing imaging fluid or a radioactive contrast enhancing fluid. 47. A method of controlling an injector in a medical imaging procedure, comprising: (a) determining at least one mathematical model to predict a time enhancement response resulting from an injection of a contrast medium;(b) determining an injection protocol to approximate a predetermined time enhancement response in a patient by determining a constrained input solution to the at least one mathematical model; and(c) using the injection protocol to control the injector during the medical imaging procedure to control the injection of the contrast medium into the patient to create an image of a region of interest. 48. The method of claim 47 further comprising the step of changing the injection protocol as a result of feedback regarding the time enhancement response during the imaging procedure. 49. The method of claim 47 further comprising the step of changing the injection protocol as a result of data regarding at least one patient physiological parameter during the imaging procedure. 50. The method of claim 47 wherein the step of determining an injection protocol to approximate the predetermined time enhancement response is accomplished using a numerical solver or a numerical optimizer. 51. The method of claim 47 wherein the constrained input solution to the mathematical model is constrained by at least one operational limitation of the injector. 52. The method of claim 47 wherein the constrained input solution to the mathematical model is constrained by at least one operational limitation related to patient safety or comfort. 53. The method of claim 47 wherein the injection of the contrast medium is commenced at one time and an image scan of the region of interest is commenced at a second time determined at least in part on the basis of the mathematical model. 54. The method of claim 53 wherein the second time is determined on the basis of a prediction of a time of attainment of a predetermined enhancement level as determined by the mathematical model. 55. The method of claim 47 wherein the at least one mathematical model is a patient transfer function for the patient based upon data specific to the patient, the at least one patient transfer function providing a time enhancement output for a given input. 56. The method of claim 55 wherein the patient transfer function is determined using a system identification model comprising parameters related to physiological parameters of the patient or is determined using a mathematic identification model determined by collecting data corresponding to a time enhancement curve resulting from the injection of the patient, wherein the mathematical identification model describes the data. 57. A method of controlling injection of a pharmaceutical fluid into a patient using an injector having a controller in communicative connection with a computer memory in a medical procedure, comprising: (a) collecting data corresponding to a patient response curve resulting from an injection of the pharmaceutical fluid;(b) choosing at least one mathematical model from a plurality of mathematical models stored in the computer memory to describe the data;(c) adapting the at least one mathematical model to the collected data; and(d) controlling the injector via the controller during the medical procedure to control the injection of the pharmaceutical fluid into the patient to create a patient response at least in part on the basis of the at least one mathematical model. 58. An imaging system, comprising: (a) an imager to create an image of a region of interest of a patient;(b) an injector adapted to inject a contrast medium; and(c) a controller in operative communication with the injector to control the injector, the controller comprising: (I) at least one patient transfer function determined for the patient based upon data specific to the patient, the at least one patient transfer function providing a time enhancement output for a given input, the data specific to the patient including at least one of an estimate of physiologic parameters of the patient, an estimate of anatomic parameters of the patient and an enhancement caused by an injection of the contrast medium into the patient; and(II) a processor to determine an injection procedure input for a desired time enhancement output using the at least one patient transfer function.